Your browser doesn't support javascript.
loading
Changes of neurocognitive status in patients with the first-episode psychosis after 18 months of treatment-A prospective cohort study.
Bosnjak Kuharic, Dina; Makaric, Porin; Kekin, Ivana; Rossini Gajsak, Linda; Zivkovic, Maja; Ostojic, Drazenka; Silic, Ante; Bajic, Zarko; Lukacevic Lovrencic, Iva; Beezhold, Julian; Rojnic Kuzman, Martina.
Afiliación
  • Bosnjak Kuharic D; University Psychiatric Hospital Vrapce, Zagreb, Croatia. Electronic address: dina.bosnjak@gmail.com.
  • Makaric P; University Psychiatric Hospital Vrapce, Zagreb, Croatia.
  • Kekin I; Department of Psychiatry, Zagreb University Hospital Centre, Kispaticeva 12, Zagreb HR-10000, Croatia.
  • Rossini Gajsak L; Neuropsychiatric Hospital "Dr. Ivan Barbot", Popovaca, Croatia.
  • Zivkovic M; Department of Psychiatry, Zagreb University Hospital Centre, Kispaticeva 12, Zagreb HR-10000, Croatia.
  • Ostojic D; University Psychiatric Hospital Vrapce, Zagreb, Croatia; Social Work Study Centre, Faculty of Law, University of Zagreb, Zagreb, Croatia.
  • Silic A; Department of Psychiatry, Sestre milosrdnice University Hospital Center, Zagreb, Croatia; Department of Psychology, University Department of Croatian Studies, University of Zagreb, Zagreb, Croatia.
  • Bajic Z; Biometrika Healthcare Research, Zagreb, Croatia; Psychiatric Hospital "Sveti Ivan", Zagreb, Croatia.
  • Lukacevic Lovrencic I; Zagreb School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Beezhold J; Norfolk and Suffolk NHS Foundation Trust, Norfolk and Norwich University Hospital, United Kingdom; Norwich Medical School, University of East Anglia, United Kingdom.
  • Rojnic Kuzman M; Department of Psychiatry, Zagreb University Hospital Centre, Kispaticeva 12, Zagreb HR-10000, Croatia; Zagreb School of Medicine, University of Zagreb, Zagreb, Croatia. Electronic address: mrojnic@gmail.com.
Psychiatry Res ; 304: 114131, 2021 10.
Article en En | MEDLINE | ID: mdl-34332430
ABSTRACT
Neurocognitive symptoms exert the most influence on treatment outcomes over the course of schizophrenia, starting from the first-episode of psychosis (FEP) onwards. Our aim was to analyze the neurocognitive status of FEP compared to healthy controls (HC), and its change after 18 months of treatment. We performed a study in a sample of 159 patients with FEP and 100 HC. We followed the patients up for 18 months after initial assessment with a battery of neurocognitive tests. We observed statistically significant improvement in the majority of neurocognitive tests after 18 months, but several tests of specific neurocognitive domains (verbal memory, language functions, executive functions) did not show significant differences between the two assessments. The results for the majority of tests obtained from patients with FEP after 18 months of treatment showed significant deterioration compared with HC. Although our study showed significant improvement of baseline neurocognitive deficits in FEP with treatment, this varied across domains and overall performance remained below that of HC. Thus, while it seems that treatment of FEP may help to delay or restore neurocognitive deterioration, it is unclear whether specific areas of neurocognitive deterioration (e.g. verbal domain) would benefit from more time or specific treatment approaches.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Psychiatry Res Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Psychiatry Res Año: 2021 Tipo del documento: Article